Clinical trials

Trials that could offer more options

Our clinical trials evaluate a targeted, oral therapy for people living with difficult-to-treat cancers. If a study could be right for you, we'll help you understand every step.

Ask about eligibility Patient FAQ

Current studies

Open and enrolling programs

Phase 3 · ASPENOVA Enrolling

Cyclin E1-positive platinum-resistant ovarian cancer

A global, registration-intent trial evaluating oral Zent-001 in biomarker-defined patients who have progressed on platinum-based therapy.

  • DesignRandomized, global
  • Key criterionCyclin E1 positive
  • DosingOral, once daily
  • Sites40+ worldwide
Check eligibility
Phase 2 · Registration-intent Advancing

Uterine serous carcinoma

A biomarker-defined study evaluating Zent-001 in uterine serous carcinoma — a population with a significant, ongoing unmet need.

  • DesignRegistration-intent
  • Key criterionBiomarker-defined
  • DosingOral, once daily
  • SitesUS & EU
Check eligibility
Find a site 40+ trial sites across the US and EU Our team can help locate the nearest participating center.

Before you decide

What to expect as a participant

Deciding whether to join a trial is personal. Here's what participation typically involves — and what we do to support you.

  • An informed consent discussion — ask anything, take your time
  • Biomarker screening at a participating site
  • Regular study visits and close monitoring by your care team
  • Travel and scheduling support where available
  • You can leave a trial at any time, for any reason
Talk to our patient team Read the FAQ
Participation is always voluntary. We're here to make sure you understand the science, the schedule and the support — so you can decide with confidence.
— Zentia Patient Information Team
Find a site near you About the therapy